OMER Competitors & Alternatives
Compare Omeros Corporation with similar stocks in the same industry
Biotechnology
OMER
Main Stock$16.86
Tradestie Score
60
Market Cap
$281.75M
P/E Ratio
13.6
Revenue Growth
0.1%
Analyst Upside
+63.1%
Top Competitors
220 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
CVAC
CureVac N.V. Ordinary Shares
|
$4.66
|
$1.22B | 7.0 | 54 | Compare |
|
ATAI
ATAI Life Sciences N.V. Common Shares
|
$7.35
|
$1.22B | - | 44 | Compare |
|
PGEN
Precigen, Inc. Common Stock
|
$6.39
|
$1.18B | - | 61 | Compare |
|
ELVN
Enliven Therapeutics, Inc. Common Stock
|
$41.93
|
$1.17B | - | 60 | Compare |
|
INVA
Innoviva, Inc. Common Stock
|
$21.06
|
$1.15B | 4.9 | 50 | Compare |
|
TRVI
Trevi Therapeutics, Inc. Common Stock
|
$12.94
|
$1.14B | - | 69 | Compare |
|
ORIC
Oric Pharmaceuticals, Inc. Common Stock
|
$13.63
|
$1.14B | - | 47 | Compare |
|
MAZE
Maze Therapeutics, Inc. Common Stock
|
$31.95
|
$1.13B | - | 40 | Compare |
|
WVE
Wave Life Sciences Ltd. Ordinary Shares
|
$3.35
|
$1.12B | - | 60 | Compare |
|
NKTR
Nektar Therapeutics
|
$38.65
|
$1.12B | - | 61 | Compare |
More OMER Analysis
Data updated: Oct 23, 2026 | Industry: Biotechnology (SIC 2834)
220 stocks in this industry